Breathe Well Live Well
 In-PharmaTechnologist.com |
Asthma sufferers could ditch daily inhalers, says UTMB
In-PharmaTechnologist.com One group took corticosteroids – the most common treatment for asthma – under the normal twice-a-day prescription, and the other only when symptoms occurred. The researchers found that symptom-based doses are not only just as effective as taking a … |
View full post on asthma – Google News
 In-PharmaTechnologist.com |
Prosonix teams with ICL to assess MCPs for COPD and asthma
In-PharmaTechnologist.com Prosonix aims to develop new treatments for respiratory diseases though an R&D accord formed with Imperial College London (ICL). |
View full post on asthma – Google News
|
New asthma treatment threatens inhaler companies
In-PharmaTechnologist.com A new oral medication for asthma sufferers could wipe out half of all business for inhaler manufacturers. Researchers, lead by Respiratory Research's Professor David Price, completed a two-year long pragmatic trial into … |
View full post on asthma – Google News